[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:cd4-cd8-ratio":3},{"name":4,"total":5,"recruiting":6,"trials":7},"CD4:CD8 ratio",1,0,[8],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06495593","Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple Sclerosis",[12],"Phase 4","ENROLLING_BY_INVITATION","2026-08-26T02:17:39.048487Z","2026-06-16T05:54:07.757786Z"]